Development and validation of novel biomarker assays for osteoarthritis

BACKGROUND: Osteoarthritis (OA) is the most common chronic joint disease usually diagnosed at relatively advanced stages when there is irreparable damage to the joint(s). Recently, we have identified two novel biomarkers C3f and V65 which appear to be OA-specific and therefore potential markers of e...

Descripción completa

Detalles Bibliográficos
Autores principales: Ourradi, Khadija, Xu, Yunhe, de Seny, Dominique, Kirwan, John, Blom, Ashley, Sharif, Mohammed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5513499/
https://www.ncbi.nlm.nih.gov/pubmed/28715494
http://dx.doi.org/10.1371/journal.pone.0181334

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5513499/
https://www.ncbi.nlm.nih.gov/pubmed/28715494
http://dx.doi.org/10.1371/journal.pone.0181334

Ejemplares similares